In 2025, the Mexico industry closed at USD 8.39 billion, in terms of market size.
Market trajectory studies signal that the Mexico Infusion Services Market is likely to generate revenue of USD 22.84 billion by 2033, with an expected CAGR of 13.3% over the projection period.
Urban private hospital networks are increasing infusion capacity to meet oncology demand as public sector infrastructure remains concentrated in major metropolitan areas.
Mexico’s Ministry of Health reports ongoing cancer incidence growth, reinforcing long-term infusion service expansion across tertiary care centers.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]